Carlos Paya

Experience

1. Collegium Pharmaceutical, Inc.Board Membercurrent2025 — presentBoston, Massachusetts, United States
2. IMU BiosciencesBoard Membercurrent2025 — presentLondon Area, United Kingdom
3. VaxcyteChairman of the Boardcurrent2022 — presentSan Francisco, California, United States
4. Highlight Therapeutics SLChairperson of the Boardcurrent2020 — presentMadrid, Spain
5. AbingworthVenture Partnercurrent2020 — present
6. Fluidigm Standard BiotoolsChairman of the Board2017 — 2024San Francisco, California, United States
7. MallinkrodtBoard Member2019 — 2022Dublin, County Dublin, Ireland
8. Immune Design CorpPresident and CEO2011 — 2019Seattle, WA
9. Elan PharmaceuticalsPresident2008 — 2011San Francisco Bay Area
10. Eli LillyVP2001 — 2008
11. Mayo ClinicProfessor of Medicine and Immunology1991 — 2001

Education

1. The University of Chicago Booth School of BusinessCEI, Executive Business Education2005 — 2006
2. Institute Pasteur, Paris, FrancePostdoctoral training, Viral Immunology1989 — 1992
3. Mayo Clinic Alix School of MedicineFellowship, Infectious Diseases and Immunology1986 — 1989
4. Mayo Clinic Alix School of MedicineResidency, Internal Medicine1983 — 1986
5. University of NavarraLicensure, Medicine1981
6. Universidad Complutense de MadridMD PhD, Medicine and Viral Immunology1975 — 1981

Skills & more

From Carlos's professional profile.

Same school

Also attended The University of Chicago Booth School of Business431

PSPrashant ShahPartner at Monta Vista CapitalNNoorPartner at Clear VenturesTTinaInvestments & Portfolio Services Team Member at Clear VenturesBPBill PescatelloInvestor at LightbankGGlebFounder and Managing Partner at iTech CapitalRRRavi RajamonyVice President at March Capital Partners

+ 425 more

Also attended Mayo Clinic Alix School of Medicine4

AEAndrew ElBardissiPartner at Deerfield Management CompanyRKRené KuijtenPartner, Head of EQT Life Sciences at EQT Life SciencesMMMichael MatlyManaging Partner at West CapitalAVAlexander VosVenture Partner at BioGeneration Ventures

Also attended University of Navarra21

AFAlba FernándezAnalyst at Inveready Technology Investment GroupCTCésar TraseiraInvestor at KfundFDFernando Díaz SolísCo-founder and Managing Partner at Kibo VenturesIEItziar EstevezPartner - Growth at Iris CapitalCCCatalina CuchyExecutive Assistant at Ysios CapitalMRManuel RavagoPrincipal, Portfolio Management at Wavemaker Partners

+ 15 more

Also attended Universidad Complutense de Madrid69

KMKike MirallesInvestment Director at Intel CapitalRGRaúl GallegoGeneral Partner at Inveready Technology Investment GroupPGPablo GoceAnalyst at Inveready Technology Investment GroupMPMaria PovedaDirector at Inveready Technology Investment GroupSWSamantha WulfsonPrincipal at FinTech CollectiveJMJosé Mª AmusáteguiCo-founder & Partner at Kibo Ventures

+ 63 more

Shared employers

Also worked at IMU Biosciences3

MAMohadeseh AbdullahiPartner at Giant Ventures Global LlpTHTimothy HainesExecutive Partner at AbingworthIDInga DeakinPrincipal at Molten Ventures

Also worked at Vaxcyte6

KVKurt von EmsterManaging Partner at AbingworthPHPatrick HeronManaging Partner at Frazier Life SciencesRHRob HopfnerManaging Director at Pivotal Life SciencesCGCristina GhenoiuPartner at Mubadala CapitalHLHeath LukatchPartner at Novo HoldingsDDDerek DiRoccoPartner at RA Capital

Also worked at Elan Pharmaceuticals2

LELars EkmanExecutive Partner, Private Equity at Sofinnova VenturesAOAlan O'ConnellPartner at Seroba Life Sciences

Also worked at Eli Lilly69

DMDavid MollerInvestor at Third Rock VenturesJGJesper GromadaInvestor at Third Rock VenturesMLMark LevinRetired Founding Partner at Third Rock VenturesRPRhonda PachecoPresident, U.S. Business Unit and U.S. Country Head at Takeda VenturesKFKjersti FrognerInvestor at Almi InvestMKMilla KoistinahoPartner, Innovestor Life Science at Innovestor Ventures

+ 63 more